Recently, a decision was made by the Ministry of Health to provide coverage for the commercially available Metadol-D product (DIN 2244290) as an alternative for patients in the community who cannot take or are not benefiting from Methadose. As of May 28, 2019, Metadol-D (10mg/mL) is eligible for regular benefit coverage through PharmaCare.
There is currently a limited supply of Metadol-D®. At this time only patients that have already been approved through the special authority request process are able to continue on this medication due to limited supply.
At the November 2018 meeting, the College Board directed the Registrar to explore implementation of mandatory medication error reporting to an independent third party. Learn more about this valuable process and how it fits into the College's Continuous Quality Improvement Program.
Many pharmacy employers will employ UBC pharmacy graduates shortly after completing their pharmacy program, but before they have become Full Pharmacists. The College would like to remind students and employers that pursuant to section 46(1)(a) and Schedule C of the HPA Bylaws, a person must be enrolled as a student in a recognized pharmacy education program in order to be eligible for Student Pharmacist registration.
Patient identification verification refers to the matching of a patient to an intended treatment. It is a key activity performed by all healthcare professionals in a hospital setting. Risk to patient safety occurs when there is a mismatch between a given patient and the pharmaceutical care intended for him or her, whether the care is in the form of dispensing a medication, monitoring a patient’s drug therapy or something as simple as discussing or requesting a patient’s information over the phone.